Trump nominates Erica Schwartz to run CDC
President Trump has selected Erica Schwartz as his nominee for the director of the Centers for Disease Control and Prevention (CDC), a crucial position that has seen frequent turnover during the second Trump administration. Schwartz brings a wealth of experience in public health, having served as deputy surgeon general in the first Trump administration and holding various health roles in the U.S. military.
Schwartz is a board-certified doctor of preventive medicine, having earned her medical degree from Brown University in 1998 and a Masters of Public Health degree from the Uniformed Services University of the Health Sciences in 2000. Additionally, she holds a law degree and is admitted to the bar in the District of Columbia.
With a distinguished career in the U.S. Navy and Coast Guard, Schwartz has held key positions, including serving as the Coast Guard’s preventive medicine chief and contributing to the Trump administration’s response to the Covid-19 pandemic. As a retired rear admiral of the U.S. Public Health Service Commissioned Corps, Schwartz is well-versed in the culture of the CDC and its employees.
Former colleagues, including Jerome Adams, the surgeon general during the first Trump administration, have praised Schwartz for her leadership and expertise. Adams personally selected Schwartz as his deputy and highlighted her decades of distinguished public service. He expressed confidence in Schwartz’s ability to lead the CDC effectively, particularly if allowed to follow scientific guidance without political interference.
However, concerns have been raised about Schwartz’s nomination, particularly regarding her accountability to Health Secretary Robert F. Kennedy Jr., who has been critical of vaccines and the CDC. Debra Houry, the former chief medical officer at the CDC, pointed out that previous director Susan Monarez faced challenges in making decisions due to political pressures. It remains to be seen how Schwartz will navigate these potential obstacles during the confirmation process.
In addition to Schwartz, Trump also appointed Sean Slovenski as CDC deputy director and chief operating officer, Jennifer Shuford as deputy director and chief medical officer, and Sara Brenner as senior counselor for public health to Kennedy. Schwartz’s nomination faces potential hurdles in the Senate, where some lawmakers may scrutinize her stance on vaccines and political affiliations.
The nomination of Schwartz comes at a critical juncture for HHS leadership positions, with ongoing tensions between Washington alliances. The administration aims to shift focus from divisive issues like vaccines to more popular topics such as food safety and drug pricing. This shift has caused dissent among some factions of the Make America Healthy Again movement, which supports Kennedy’s vaccine safety advocacy.
If confirmed, Schwartz would be the second full-time director of the CDC this term, following Monarez’s brief tenure. The CDC has been under interim leadership since Monarez’s dismissal, with Jay Bhattacharya currently serving as the de facto acting director. As Schwartz navigates the confirmation process, her experience and commitment to public health will be under scrutiny by lawmakers and stakeholders alike. The appointment of an acting director for the Centers for Disease Control and Prevention (CDC) has hit a roadblock due to a provision in the Federal Vacancies Reform Act. Despite the need for a permanent director to lead the agency during a critical time, the limitations set by the Act prevent Debora But Bhattacharya from using the title of acting director for an extended period.
The administration’s initial nominee, former Florida congressman Dave Weldon, faced obstacles in the Senate confirmation process which ultimately led to the withdrawal of his candidacy. It was clear that he did not have enough support to be confirmed, prompting the administration to reconsider their options for the CDC director position.
The Senate’s health committee, chaired by Sen. Bill Cassidy (R-La.), will play a crucial role in the nomination process for a new CDC director. Sen. Cassidy, a physician and advocate for vaccination, holds significant influence in the decision-making process. His previous support for controversial nominees, like Dr. Robert Kennedy, highlights the importance of his stance on key healthcare issues.
As the search for a new CDC director continues, the Senate’s health committee will need to carefully consider the qualifications and capabilities of potential candidates. The CDC plays a vital role in public health and disease prevention, making it essential to have strong leadership at the helm of the agency. With the support of key stakeholders like Sen. Cassidy, the nomination of a new director will be a critical step in ensuring the CDC can effectively fulfill its mission to protect the health of all Americans.
